Clinical trial Recruiting at 1 site Observational Ages 7 to 17

Pediatric OCD and gut-brain microbiome links in kids on SSRIs

Official title: Pathogenesis of Pediatric Obsessive-compulsive Disorder: Based on the Microbiota-gut-brain Axis

Run by Shanghai Mental Health Center · NCT06754319 · Data updated 2026-11-12

This study tests whether the gut microbiome and related markers change in children and teens with OCD when treated with SSRIs, and compares those results with kids who have OCD with tic disorders and healthy peers.

Quick facts

Study typeObservational
Ages7 Years to 17 Years
SexAll
Enrollment125 (estimated)
SponsorShanghai Mental Health Center
Academic / other
Locations1 site (Shanghai, Shanghai Municipality)
StatusRecruiting
StartedAugust 24, 2024
Main results expectedDecember 31, 2027
Study endsDecember 31, 2027
Registry record updatedAugust 3, 2026
Trial IDNCT06754319 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are 7-17 year-olds with OCD (with or without tic disorders), drug-naïve or off meds for 8 weeks, and an IQ of 80 or higher.

Probably not a fit

Patients with significant medical or neurological conditions, recent antibiotic or probiotic use, or poor response potential to SSRIs may see limited benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study analyzes the microbiota-gut-brain axis in pediatric OCD by integrating gut microbiota analysis, serum metabolomics, neuroimaging, and EEG before and after SSRI treatment. Participants include 7-17 year-olds with OCD, with or without tic disorders, and a healthy control group. The goal is to identify biomarkers and potential pathways that may contribute to OCD and to see how treatment influences these factors. Data will be used to explore possible new targets for intervention and to inform treatment optimization. The study is conducted at Shanghai Mental Health Center and is sponsored by the same institution.

Why it matters

Potential benefit: If successful, findings could help tailor future treatments by identifying microbiome-related targets and biomarkers.

How similar studies have gone: Similar approaches in related pediatric neuropsychiatric research have yielded insightful associations between microbiota and brain function, though direct causal links remain to be established in OCD.

Who can join: the full rules

Show full inclusion / exclusion criteria
We recruited outpatient children and adolescents with OCD confirmed by the Kiddie Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (4th edition). The following inclusion and exclusion criteria were also applied:

Inclusion Criteria:

(1) 7-17 years old, (2) Y-BOCS score ≥16, (3) with or without a history of TD, (4) Drug-naïve or drug-free for 8 weeks, (5) Wechsler IQ score ≥ 80.

Exclusion Criteria:

* History of serious medical, neurological illness or other psychotic disorders other than OCD (tic disorder excepted).
* Previous exposure to cognitive behavioral therapy (CBT) for OCD or TD.
* serious suicide risk.
* Has taken antibiotics, probiotics, prebiotics, corticosteroids, nonsteroidal anti-inflammatory drugs (NSAIDs), or immunosuppressants within the past 8 weeks.
* Has a history of gastrointestinal diseases such as inflammatory bowel disease, irritable bowel syndrome, constipation, hemorrhoids, or a history of gastrointestinal surgery, or has a history of autoimmune diseases such as rheumatoid arthritis or systemic lupus erythematosus.
* Participants with claustrophobic, heart pacemaker, mechanical heart valve, mechanical implant such as an aneurysm clip, hip replacement, or any other pieces of metal that have accidentally entered their body.

Where it's running

  • Shanghai Mental Health Center
    Shanghai, Shanghai Municipality, China
    Recruiting

Study contacts

  • Principal investigator: Zhen Wang, PhD, MD — Shanghai Mental Health Center
  • Study coordinator: Zhen Wang, PhD, MD
  • Email: wangzhen@smhc.org.cn
  • Phone: +86 34773516

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.